Stromelysin is a collagenase-related connective-tissue-degrading metalloproteinase. We have detected RNAs capable of hybridizing to a rat stromelysin cDNA in II of 69 human tumours tested. Molecular cloning of cDNAs to these RNAs has identified them as a mixture of stromelysin RNA and a transcript of a hithertoundescribed related human gene, the stromelysin-2 gene. We have also isolated cDNAs corresponding to a more distantly related new human gene, the pump-I gene. A comparison of the cDNA-derived amino acid sequences of stromelysin-2 and pump-I with the known sequences of stromelysin and collagenase reveals significant similarities, with conservation of sequence motifs believed to have functional importance in metalloproteinase action. We conclude that the collagenase gene family in humans consists of at least four members, and speculate that expression of these genes plays a role in cancer.
INTRODUCTION
Tumour invasion and metastasis are of fundamental importance in cancer. It is a well established concept that these processes require an enzymic degradation of the host interstitial matrix. This concept is supported by many reports of increased proteolytic activities in tumour cells (reviewed in [1] ). For instance, tumour cells release collagenases with specificity for interstitial collagens types 1-111 or basement-membrane type IV collagen (see [1] [2] [3] for references).
Stromelysin is a metalloproteinase related to collagenase (there is about 55 % similarity in their amino acid sequences) whose substrates include proteoglycans and fibronectin, but not type I collagen [4, 5] . Little is known about the expression of stromelysin in human tumours. However, the apparent rat homologue of stromelysin, transin, is induced in rat-embryo fibroblasts by oncogenic transformation [6, 7] , and transin mRNA can be detected in mouse skin squamous-cell carcinomas, but not in premalignant benign papillomas or normal mouse epidermis [8] . These observations suggest that transin/stromelysin may be involved in tumour invasion in these rodent systems. Given the crucial importance of tumour invasion and metastasis in cancer, and the role ascribed to proteinases in these phenomena, it was important to ascertain whether stromelysin RNA or related species could be detected in human tumours. In the present paper we report the results of a search for such species in 69 human tumours of various different types. This search has led to the identification of two new members of the human collagenase gene family. METHODS Tumour samples RNA blotting was used to detect RNA species capable of hybridizing to transin cDNA in various human tumours. Primary-tumour samples, 50 in all, were tested, including 32 adenocarcinomas (24 breast, three thyroid, two colon, one rectum, one lung and one endometrium), four upper-respiratory-tract carcinomas, two basal-cell carcinomas, one malignant melanoma, two sarcomas, one teratocarcinoma, four squamous-cell carcinomas of the lung, two squamous-cell -carcinomas of the lip, one squamous-cell carcinoma ofthe forehead and one thyroid goitre. Samples were also prepared from 12 metastatic lymph nodes (derived from five breast, one laryngeal and one vulval carcinoma, three malignant melanomas and two Hodgkin's disease) and seven metastatic dermal nodules (derived from four breast carcinomas, two malignant melanomas and one liposarcoma), one omental metastasis of an endometrial adenocarcinoma and one nasal mucosa metastasis of a malignant melanoma. Normal tissues were obtained from macroscopically non-invaded lung, skin, colon, rectum and thyroid from nine subjects carrying carcinomas, the site of sampling being at least 4 [9] . RNA samples (20 jug) were subjected to gel electrophoresis as described elsewhere [6, 7] [22] .
described [6] ) were carried out under conditions of moderate stringency.
[5 x SSC/50 % (v/v) formamide] as described previously [6, 7] . Membranes were washed in 0.36 M-NaCl/20 mM-sodium phosphate, pH 7.7, containing 2 mM-EDTA and 0.1 % SDS at 50 'C. RNA was shown to be intact by re-hybridization of samples to a probe for a ubiquitous RNA [10] . Analysis of cloned cDNAs Poly(A)+ RNA was prepared [11] from a pool of those RNA samples which contained material hybridizing to transin cDNA. The poly(A)+ RNA was used for the creation of a cDNA library in the vector Agtl0 [12] , using the adaptor-tailing technique of Haymerle et al. [13] . About 106 recombinant phages were obtained from 4 ,ug of poly(A)+ RNA. Of these, 3 x 106 phages were screened for inserts capable of hybridizing to transin cDNA by standard techniques [11] . Hybridizations were carried out as for the RNA blotting experiments, except that low stringency conditions were used (6 x SSC/40 % formamide). Positively responding phages were plaquepurified and their cDNA inserts, bordered by restrictionendonuclease-EcoRI sites, transferred to the EcoRI site of plasmid pUN121 [14] . Resulting plasmids were amplified and used as a source of cloned cDNAs. Fragments of cloned cDNAs were transferred to the vectors Ml 3tgl 30/131 [15] for sequencing by the dideoxy method [16] described previously. When restrictionenzyme fragments of the cDNAs were introduced into the M1 3 vectors, the universal sequencing primer was used for sequencing from the corresponding site. To fill some gaps, specific oligonucleotide sequencing primers were used whose sequences were based on those already obtained by using the universal primer. The sequencing strategies are shown in Figs. 2 and 3 (below). In this way all restriction sites used for sequencing were overlapped. The sequences of stromelysin-2 and pump-I cDNAs shown in Figs. 2 and 3 (below) were determined on both strands.
RESULTS AND DISCUSSION
RNA blotting was used to identify species capable of hybridizing to a transin (rat stromelysin) cDNA probe in RNA from various human tumours (see the Methods section for details). Six of the 50 primary tumours and five of the 19 metastases tested contained a 1.9-kb RNA detectable with the transin cDNA probe (see Fig. 1 for some examples). In primary tumours this RNA was found in six of 13 tumours tested with a squamous component, namely two upper-respiratory-tract carcinomas, one basal-cell carcinoma and squamous-cell carcinomas of the lung, lip and forehead (one of each). We did not detect the RNA in any of the 32 adenocarcinomas or two sarcomas, nor in any of the normal tissues tested. Among the five metastatic-tumour samples expressing the 1.9-kb RNA, one was derived from a primary tumour with a squamous component (squamous-cell carcinoma of the vulva), and the other three had metastasized to tissues with a squamous component (two dermal nodules of breast carcinomas and one metastasis of a malignant melanoma in the nasal cavity). The remaining positive sample was an omental metastasis of an endometrial adenocarcinoma.
Although transin appears to be the rat homologue of stromelysin, it was necessary to determine whether the 1.9-kb RNA was effectively stromelysin RNA. To this end we prepared a cDNA library in the bacteriophage vector AgtlO from a mixture of RNAs from the 'positive' tumours and screened it by using the transin cDNA probe. Conditions of reduced stringency relative to those used to screen the RNA samples were chosen, in the hope of isolating cDNAs corresponding to all the stromelysinrelated RNAs present in the tumour samples.
Screening of 3 x 105 plaques yielded 24 strongly positive plaques and nine weakly positive plaques. Analysis of the cDNA inserts of the positive phages by a combination of restriction-enzyme mapping, nucleotide sequencing and cross-hybridization experiments allowed us to identify four of the strongly positive cDNAs as stromelysin cDNA [5] and four of the weakly positive cDNAs as collagenase cDNAs [5, 17] . The remaining 20 strongly positive cDNAs appeared to be derived from one new gene, which we decided to call the 'stromelysin-2' gene. The five non-collagenase weakly positive cDNAs appeared to be derived from a second new gene, which we decided to call the 'pump-i' (for putative metalloproteinase) gene. From the frequency of stromelysin versus stromelysin-2 cDNA clones obtained we conclude that the 1.9-kb RNAs seen in Fig. 1 are predominantly stromelysin-2 RNAs. It should be stressed that the higher stringency conditions of hybridization used for the RNA blotting experiments (compared with the phage screening experiments) would not have allowed detection of pump-I or collagenase RNAs, which are thus absent from Fig. 1 . The pump-I cDNA probe will detect a 1.2-kb RNA in the pool of RNAs used to create the cDNA library, however (results not shown).
The longest stromelysin-2 (1.7 kb) and pump-I (1.1 kb) cDNAs appear to be complete at their 3'-ends, as they carry a poly(A) tail (results not shown) preceded by the polyadenylation signal AATAAA [18] . The stromelysin-2 cDNA has a coding capacity for a putative protein of 476 amino acids, which we term 'stromelysin-2' (Fig. 2) . The pump-1 cDNA has coding capacity for a putative protein of 267 amino acids, which we term 'pump-I' (Fig. 3) . The sequences of these two proteins are compared in Fig. 4 with those of collagenase and stromelysin. This comparison reveals that stromelysin-2 is similar, over its entire length, to these enzymes (overall TTC CCT AGA CTA ATA GCT GAT GAC TTT CCA GGA GTT GAG CCT MG GTT GAT GCT GTA TTA CAG GCA TTT The 'missing' C-terminal sequences are not due to a cloning artefact, as the same sequence was determined from two independent cDNA clones, both of which contained a stop codon after the codon coding for amino acid 267 of pump-i, and an equivalent 3'-untranslated region. A comparison of the sequence of pump-I with the corresponding regions of stromelysin and collagenase reveals a sequence similarity of 49 and 44 % respectively. Stromelysin-2 appears thus to be a normal, and pump-I a truncated, member of the collagenase family. Although a direct experimental test is necessary to determine whether pump-I and stromelysin-2 are secreted proteinases, their sequences are consistent with this possibility. As mentioned above, both proteins have candidate signal sequences. In addition, both proteins contain the region corresponding to the putative zincchelating region of stromelysin and collagenase, with conservation of the histidine residues (* in Fig. 4 ) believed to participate in binding the zinc atom known to be at the active site of all metalloproteinases studied in any detail [5] .
Stromelysin and collagenase are secreted as proenzymes [5, 19] . The amino acids found between the signal sequence and the phenylalanine at the N-termini of the activated forms of these enzymes (see A, Fig. 4 ) are cleaved off during activation. Just before these phenylalanine residues lies a conserved block of eight amino acids (underlined in Fig. 4 ). These amino acids are strictly conserved in stromelysin-2 and pump-1. Stromelysin-2 and pump-I have thus all the hallmarks of secreted activable metalloproteinases of the collagenase family.
The 'truncated' structure of pump-I is of particular interest in view of the fact that transin (rat stromelysin) comprises two separate domains. We showed previously that the C-terminal moiety of transin (amino acids 288-475) has weak, but statistically significant, similarity to hemopexin [7] . This observation holds true also for collagenase and stromelysin (results not shown, but the beginning of this moiety of these proteins is shown by an arrow marked 'C' in Fig. 4) . We [5, 17] . A Indicates the N-terminus of activated collagenase [5, 19] . A conserved sequence of eight amino acids just upstream is underlined. The arrow marked 'N' shows where the end of the N-terminal moiety of transin (rat stromelysin) lines up on the stromelysin and collagenase sequences. This moiety can act as a proteinase. The arrow marked 'C' shows the beginning of the C-terminal hemopexin-like moiety of collagenase family enzymes. moiety of transin, i.e. pump-I has a potential proteinase domain but not a hemopexin-like domain. The function of the hemopexin-like domain of collagenase-family proteinases is unknown. We may speculate that it might be involved in controlling enzyme activation, conferring substrate selectivity or binding of inhibitors. The absence of this domain from pump-I would in these cases have important implications.
In conclusion, we have described two new members of the collagenase gene family, which thus consists of at least four members in humans: genes for collagenase, stromelysin, stromelysin-2 and pump-1. The parent family member, collagenase, is an important enzyme which plays a role in various pathological conditions such as cancer and rheumatoid arthritis [1] . The discovery of new collagenase family members is thus of some interest, and it will be of importance to characterize the proteins stromelysin-2 and pump-I and to investigate the factors controlling their expression.
Rat stromelysin RNA is induced by oncogenes in cultured cells [6, 7] . Many human tumours contain activated oncogenes [20] . It is thus of interest that transcripts of the stromelysin or stromelysin-2 genes can be detected in some human tumours. These transcripts were preferentially detected in tumours with a squamous component or in metastases of tumours in epidermal tissues. Tumour samples are heterogeneous, and mesenchymal cells (fibroblasts, macrophages) are often found in high amounts in the vicinity of tumour cells. Production and release of proteinases could thus result from tumour-cell-host-tissue interactions [21] . The material described here should allow use of 'in situ' hybridization techniques to address this question. It is interesting to note that most of the stromelysin/ stromelysin-2-positive tumours are rapidly evolutive (head and neck, spinal-cell carcinoma) or advancedstage diseases (poorly differentiated lung squamous-cell carcinomas). These preliminary results raise the question as to whether expression of these genes may contribute to the highly malignant state of epidermoid carcinomas. Further analysis of a wide spectrum of these tumours and extension of these studies to expression of the pump-I gene is called for.
